Cannabics Pharmaceuticals Stock Buy Hold or Sell Recommendation
| CNBX Stock | USD 0.01 0 15.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cannabics Pharmaceuticals is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Cannabics Pharmaceuticals given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Cannabics Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Cannabics Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Cannabics and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cannabics Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Cannabics |
Execute Cannabics Pharmaceuticals Buy or Sell Advice
The Cannabics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cannabics Pharmaceuticals. Macroaxis does not own or have any residual interests in Cannabics Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cannabics Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Cannabics Pharmaceuticals Trading Alerts and Improvement Suggestions
| Cannabics Pharmaceuticals had very high historical volatility over the last 90 days | |
| Cannabics Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Cannabics Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Cannabics Pharmaceuticals currently holds 1.6 M in liabilities with Debt to Equity (D/E) ratio of 0.48, which is about average as compared to similar companies. Cannabics Pharmaceuticals has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cannabics Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Cannabics Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cannabics Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cannabics to invest in growth at high rates of return. When we think about Cannabics Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.72 M) with profit before overhead, payroll, taxes, and interest of 7.16 K. | |
| Cannabics Pharmaceuticals currently holds about 96.28 K in cash with (1.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of Cannabics Pharmaceuticals shares are held by company insiders |
Cannabics Pharmaceuticals Returns Distribution Density
The distribution of Cannabics Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Cannabics Pharmaceuticals' future price movements. The chart of the probability distribution of Cannabics Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Cannabics Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cannabics Pharmaceuticals returns is essential to provide solid investment advice for Cannabics Pharmaceuticals.
| Mean Return | 0.17 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 8.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cannabics Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cannabics Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cannabics Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cannabics Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cannabics pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.30 | |
β | Beta against Dow Jones | -1.21 | |
σ | Overall volatility | 8.96 | |
Ir | Information ratio | 0.01 |
Cannabics Pharmaceuticals Volatility Alert
Cannabics Pharmaceuticals is displaying above-average volatility over the selected time horizon. Cannabics Pharmaceuticals is a penny stock. Even though Cannabics Pharmaceuticals may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Cannabics Pharmaceuticals or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Cannabics instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Cannabics Pharmaceuticals Fundamentals Vs Peers
Comparing Cannabics Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cannabics Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Cannabics Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cannabics Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Cannabics Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cannabics Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cannabics Pharmaceuticals to competition |
| Fundamentals | Cannabics Pharmaceuticals | Peer Average |
| Return On Equity | -42.89 | -0.31 |
| Return On Asset | -1.0 | -0.14 |
| Current Valuation | 6.67 M | 16.62 B |
| Shares Outstanding | 1.26 M | 571.82 M |
| Shares Owned By Insiders | 57.59 % | 10.09 % |
| Price To Earning | 31.09 X | 28.72 X |
| Price To Book | 20.39 X | 9.51 X |
| Price To Sales | 7,566 X | 11.42 X |
| Gross Profit | 7.16 K | 27.38 B |
| EBITDA | (3.52 M) | 3.9 B |
| Net Income | (3.72 M) | 570.98 M |
| Cash And Equivalents | 96.28 K | 2.7 B |
| Cash Per Share | 0.08 X | 5.01 X |
| Total Debt | 1.6 M | 5.32 B |
| Debt To Equity | 0.48 % | 48.70 % |
| Current Ratio | 0.11 X | 2.16 X |
| Book Value Per Share | (1.57) X | 1.93 K |
| Cash Flow From Operations | (1.68 M) | 971.22 M |
| Earnings Per Share | (3.80) X | 3.12 X |
| Number Of Employees | 5 | 18.84 K |
| Beta | 1.52 | -0.15 |
| Market Capitalization | 123.28 K | 19.03 B |
| Total Asset | 811.17 K | 29.47 B |
| Z Score | -13.2 | 8.72 |
| Net Asset | 811.17 K |
Cannabics Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cannabics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cannabics Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Cannabics Pharmaceuticals? Buying financial instruments such as Cannabics Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cannabics Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rubber and Plastic Products Thematic Idea Now
Rubber and Plastic Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Rubber and Plastic Products theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rubber and Plastic Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.